4.6686

5.86% 0.2586

Orchestra Biomed Holdings Inc (OBIO)

Overview News Price History Discussions Forecast

Orchestra Biomed Holdings Inc stock is traded at $4.6686, with a volume of 157.24K. It is up +5.86% in the last 24 hours and up +26.86% over the past month. Orchestra BioMed Holdings Inc is a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships with medical device companies. The company's flagship product candidates are Atrioventricular Interval Modulation Therapy (AVIM Therapy) for the treatment of hypertension, the risk factor for death, and Virtue Sirolimus AngioInfusion Balloon (Virtue SAB) for the treatment of atherosclerotic artery disease, the cause of mortality. It has one reportable segment, which consists of the development of clinical and preclinical product candidates through risk-reward sharing partnerships with medical device companies.

Previous Close:

$4.41

Open:

$4.41

24h Volume:

157.24K

Relative Volume:

0.50

Market Cap:

$281.23M

Revenue:

$32.72M

Net Income/Loss:

$-54.64M

P/E Ratio:

-4.1399

EPS:

-1.1277

Net Cash Flow:

$-55.08M

1W Performance:

+4.67%

1M Performance:

+26.86%

6M Performance:

+21.57%

1Y Performance:

+82.00%

1-Day Range:

$4.36

$4.72

1-Week Range:

$4.20

$4.72

52-Week Range:

$2.20

$5.424

Orchestra Biomed Holdings Inc Stock (OBIO) Company Profile

Name

Orchestra Biomed Holdings Inc

Sector

Healthcare (1089)

Industry

Biotechnology (604)

Phone

646-343-9298

Address

150 UNION SQUARE DRIVE, NEW HOPE

Employee

Twitter

Next Earnings Date

2026-08-11

Latest SEC Filings

OBIO's Discussions on Twitter

Compare OBIO vs VRTX, REGN, ARGX, RVMD, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
OBIO Orchestra Biomed Holdings Inc	4.679	265.06M	32.72M	-54.64M	-55.08M	-1.1277
VRTX Vertex Pharmaceuticals Inc	515.63	128.19B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	807.01	82.72B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	991.71	53.26B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	213.05	43.66B	742.00K	-1.37B	-1.07B	-7.0731
ONC Beone Medicines Ltd Adr	362.46	39.31B	5.76B	514.49M	1.10B	4.4813

Orchestra Biomed Holdings Inc Stock (OBIO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-10-25	Initiated	TD Cowen	Buy
Aug-20-25	Downgrade	BTIG Research	Buy → Neutral
Mar-20-25	Initiated	BTIG Research	Buy
Jan-02-25	Initiated	Barclays	Overweight
Aug-22-24	Initiated	H.C. Wainwright	Buy
Jul-25-24	Initiated	B. Riley Securities	Buy
Jan-19-24	Initiated	Jefferies	Buy
Feb-24-23	Initiated	Piper Sandler	Overweight
Feb-07-23	Initiated	Chardan Capital Markets	Buy

View All

Orchestra Biomed Holdings Inc Stock (OBIO) Latest News

Aug 16, 2026

Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

Aug 16, 2026

Aug 14, 2026

Orchestra BioMed (OBIO) director withholds 3,761 shares to cover RSU tax bill - Stock Titan

Aug 14, 2026

Orchestra BioMed (OBIO) director uses 5,145 shares to cover RSU tax withholding - Stock Titan

Aug 14, 2026

Orchestra BioMed (OBIO) director has 4,885 shares withheld for RSU tax - Stock Titan

Aug 14, 2026

Orchestra BioMed (OBIO) director reports 4,238 RSU tax-withholding shares - Stock Titan

Aug 14, 2026

Research Analysts Offer Predictions for OBIO Q3 Earnings - MarketBeat

Aug 14, 2026

Aug 13, 2026

Wall Street Analysts Are Bullish on Top Healthcare Picks - theglobeandmail.com

Aug 13, 2026

Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Consensus Forecasts Have Become A Little Darker Since Its Latest Report - simplywall.st

Aug 13, 2026

Aug 11, 2026